Livalo
Product indicated to manage hypercholesterolaemia and designed to support cardiovascular health by reducing cholesterol production.
Strengths: 1 · 2 · 4mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Livazo
- Therapeutic class
HMG-CoA Reductase Inhibitor
- Pharmacological class
Statin
- Minor side effects
muscle pain; constipation; diarrhoea; back pain
- Moderate side effects
insomnia; elevated liver enzymes
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Kowa
- Onset Time
2–4 weeks
- Duration
24 hours
- Storage instructions
Store in a cool, dry place, away from sunlight.
- Drug interactions
erythromycin; ciclosporin; warfarin
- Age restrictions
Not recommended for children under 6 years.
- Pregnancy and breastfeeding
Pregnancy: Contraindicated. Breastfeeding: Contraindicated.
Contraindications
hypersensitivity; active liver disease; pregnancy; breastfeeding; concurrent use with ciclosporin
Precautions and warnings
monitor liver function; report any unexplained muscle pain; use with caution in elderly
Serious side effects
rhabdomyolysis — requires immediate medical attention; myopathy — requires immediate medical attention; hepatitis — requires immediate medical attention
Patient summary
Product indicated to manage hypercholesterolaemia and designed to support cardiovascular health by reducing cholesterol production.
Mechanism of action
This medicine acts as an HMG-CoA reductase inhibitor, blocking the enzyme responsible for cholesterol production in the liver, which lowers blood cholesterol levels.
Livalo
Product indicated to manage hypercholesterolaemia and designed to support cardiovascular health by reducing cholesterol production.
Editorial Notes
- Active ingredient(s): Pitavastatin
- Listed indication(s): Hypercholesterolaemia
Usually available as
- 180 tablets - 1 mg1063-1-mg-18180
- 120 tablets - 2 mg1063-2-mg-18184
- 60 tablets - 4 mg1063-4-mg-18187